We showed that Sf3b1-K700E impacted alternative RNA splicing of nuclear factor of activated T cells C1 (Nfatc1) and activated mTOR signaling and the MYC pathway, contributing to CLL acceleration. This evidence concerns the gene NFATC1 and B-cell chronic lymphocytic leukemia.